Skip to content

Thursday, April 30, 2026

Latest:

Method reveals 3D structures of RNA-protein complexes in living cells
Stress through the decades: A guide to coping at any age
From serum to supplement: How niacinamide supports healthier skin
Children survive blood clots, but are we failing them afterward?
Multipronged approach distinguishes gene function changes that promote Parkinson’s disease from those that confer protection

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

ACTL6A

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: Breast cancer cell clusters

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951